Are IL-10+ regulatory Th17 cells implicated in the sustained response to glucocorticoid treatment in patients with giant cell arteritis? Comment on the paper of Espigol-Frigole et al

Ann Rheum Dis. 2013 May;72(5):e3. doi: 10.1136/annrheumdis-2013-203439. Epub 2013 Mar 8.
No abstract available

Publication types

  • Letter

MeSH terms

  • Biopsy
  • Forkhead Transcription Factors / immunology
  • Giant Cell Arteritis / blood
  • Giant Cell Arteritis / drug therapy
  • Giant Cell Arteritis / immunology*
  • Glucocorticoids / therapeutic use
  • Humans
  • Interleukin-10 / blood
  • Interleukin-10 / immunology*
  • Interleukin-17 / biosynthesis
  • Interleukin-17 / immunology*
  • Recurrence
  • Temporal Arteries / immunology*
  • Temporal Arteries / pathology
  • Th17 Cells / immunology*

Substances

  • FOXP3 protein, human
  • Forkhead Transcription Factors
  • Glucocorticoids
  • Interleukin-17
  • Interleukin-10